Benzinga - Thu, 01 Apr 2021 08:00:00 -0400
Benzinga - Thu, 25 Mar 2021 14:45:29 -0400
Benzinga - Tue, 23 Mar 2021 19:12:00 -0400
Benzinga - Tue, 23 Mar 2021 07:50:00 -0400
Benzinga - Wed, 17 Mar 2021 07:09:50 -0400
Benzinga - Wed, 10 Mar 2021 17:01:09 -0400
Benzinga - Wed, 10 Mar 2021 08:25:58 -0400
Benzinga - Wed, 10 Mar 2021 05:03:56 -0400
Benzinga - Sat, 06 Mar 2021 11:57:57 -0400
Benzinga - Mon, 22 Feb 2021 09:52:46 -0400
Benzinga - Fri, 15 Jan 2021 08:32:12 -0400
Benzinga - Fri, 15 Jan 2021 06:49:42 -0400
Benzinga - Wed, 06 Jan 2021 16:48:18 -0400
Benzinga - Wed, 06 Jan 2021 10:20:00 -0400
Benzinga - Mon, 04 Jan 2021 08:03:03 -0400
load more
Sector: Health Care.Industry: Biotechnology
Lantern Pharma Inc is a clinical-stage biotechnology company. It is focused on leveraging artificial intelligence machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from targeted oncology therapies. The firm's pipeline of development programs involves three small molecule drug candidates namely LP-100, LP-184, and LP-300.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-12
REV
Q4 2020Est.ActualSurprise
EPS-0.450-0.470 -0.0200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
LTRNLantern Pharma-5.96%179.7M

Lantern Pharma Company Questions & Answers

Q

How do I buy Lantern Pharma (LTRN) stock?

A

You can purchase shares of Lantern Pharma (NASDAQ: LTRN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lantern Pharma's (LTRN) main competitors?

A

Other companies in Lantern Pharma’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and DiaMedica Therapeutics (NASDAQ:DMAC).

Q

What is the target price for Lantern Pharma?

A

The latest price target for Lantern Pharma (NASDAQ: LTRN) was reported by Colliers Securities on 2020-07-28. The analyst firm set a price target for 24.00 expecting LTRN to rise to within 12 months (a possible 49.16% upside). 1 analyst firms have reported ratings in the last year.

Q

How much is Lantern Pharma (LTRN) stock ?

A

The stock price for Lantern Pharma (NASDAQ: LTRN) is $16.09 last updated Mon Apr 12 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Q

When is the next Lantern Pharma (LTRN) dividend?

A

There are no upcoming dividends for Lantern Pharma.

Q

When is Lantern Pharma (NASDAQ:LTRN) reporting earnings?

A
Lantern Pharma’s Q1 earnings are confirmed from now on May 12, 2021.
Q

When is the upcoming split for LTRN?

A

There is no upcoming split for Lantern Pharma.